Direct oral anticoagulants in patients with hematologic malignancies
Alessandra Serrao, Antonio Chistolini(Sapienza University of Rome), Silvio Ligia(Sapienza University of Rome), Cristina Santoro(Sapienza University of Rome), Giulia De Luca(Istituto Pasteur), Maria Lucia De Luca(Sapienza University of Rome), Massimo Breccia(Policlinico Umberto I), Sara Mohamed(Royal College of Surgeons in Ireland - Bahrain), Antonietta Ferretti(Policlinico Umberto I), Luciano Fiori(Sapienza University of Rome), Gianfranco Lapietra(Sapienza University of Rome)
Cited by 14
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
|Cytokine|2015|505
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Differences among young adults, adults and elderly chronic myeloid leukemia patients
|Annals of Oncology|2014|99